Privacy AI
Regulatory

Health data compliance, handled.

Tell us what you need. We'll tell you what it takes and how long, before you commit.

Contact us

Summary

Contact us

Biden's New Approach to US Personal Data Transfers

‍

The Biden Administration issued an executive order authorizing the Department of Justice (DOJ) and other federal agencies to take steps to prevent “the large-scale transfer of Americans’ personal data to countries of concern.” It represents an effort by the administration to put more safeguards on the data broker industry and limit the ability of US adversaries to purchase granular data on American citizens.

‍

The Biden Administration has enacted an executive order empowering the Department of Justice (DOJ) and additional federal bodies to act against the significant movement of personal data of Americans to nations deemed as threats. This move aims to bolster the protections around the data brokerage industry and curb the potential for adversaries of the U.S. to acquire detailed information about American individuals.

Furthermore, the order mandates the following actions:

  • It directs the Committee for the Assessment of Foreign Participation in the United States Telecommunications Services Sector (Committee) to continually manage the national security and law enforcement dangers posed by the access of 'countries of concern' to extensive sensitive personal data as outlined in this directive. This applies to any new or existing application or license the Committee reviews concerning submarine cable systems' landing or operation.
  • It calls upon the Secretary of Defense, the Secretary of Health and Human Services, the Secretary of Veterans Affairs, and the Director of the National Science Foundation to explore actions, including the enactment of regulations, guidance, or directives. These actions aim to block assistance that grants 'countries of concern' or specified entities access to the bulk sensitive personal data of U.S. citizens, particularly data related to personal health and human genomic information.
  • It instructs the Director of the Consumer Financial Protection Bureau (CFPB) to assess steps, in line with the CFPB's legal powers, to counter this threat dimension and to strengthen adherence to Federal consumer protection laws.
  • It requires the Attorney General, the Secretary of Homeland Security, and the Director of National Intelligence, in collaboration with leaders of pertinent agencies, to "recommend measures to identify, evaluate, and counteract national security threats stemming from past transfers of bulk sensitive personal data of U.S. individuals to countries of concern.

‍

‍

Read more

‍

Contact us

FAQs

Our frequently questions

No items found.

Find out how iliomad can help your company.

[Map placeholder]
Only visible in production
38.709099
-39.182035
1.6
6d17042a3425c5b3
Your message has been received!
We'll get back to you as soon as possible.
Something went wrong, please try again.
Home

Discover our latest articles

View All Blog Posts
Abstract digital network connecting hospital icons, AI circuit patterns and GDPR shield symbols on a dark blue background, representing healthcare data protection themes
October 28, 2026
Healthtech
Data Breach & Cybersecurity
GDPR
Regulation
LLMS

Healthcare AI Agents, Vendor Breaches and GDPR Reforms: Weekly Privacy and Regulation Digest

This week's digest covers autonomous AI agent risks, a wave of US healthcare vendor breaches, the EU Digital Omnibus GDPR mandate and Swiss voice-biometric enforcement.

Clinical study protocol open on a desk beside a GDPR compliance checklist and a stethoscope, representing data protection obligations in clinical research
October 26, 2026
GDPR
DPIA
Health Data Strategy
Regulations & Guidelines
Regulation

Clinical study protocol data protection: a practical guide for sponsors

Learn how to embed GDPR-compliant data protection into your clinical study protocol. Practical guidance on Section 13, DPIAs, transfers and local formalities.

A researcher reviews a clinical site agreement alongside export control documentation for cross-border data transfer compliance
October 23, 2026
Regulations & Guidelines
Clinical Trials
Regulation
Consent Forms
Big Data

Clinical Site Agreement: Navigating US Export Control Review of Cross-Border Data Transfers in Clinical Trials

Learn how institutional export control policies at clinical sites affect cross-border data transfers in trials, even below DOJ Bulk Data Rule thresholds.